Dechra Pharmaceuticals (DPH)


Latest News

Additional Listing

RNS Number: 8491H Dechra Pharmaceuticals PLC 15 March 2018 15 March 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) Additional Listing An application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 70,000 ordinary shares of 1 pence each (the "Shares") to be admitted to the Official List. These Sha...

Block listing six monthly return

RNS Number: 7543H Dechra Pharmaceuticals PLC 15 March 2018 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris . Date: 15 March 2018 Name of applicant: Dechra Pharmaceuticals PLC Name of scheme: Long-Term Incentive Scheme Period of return: From: 15 September...

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Ian Page, Chief Executive Officer, exercised 1,465 shares in the company on the 2nd March 2018 at a price of 614.00p. The D...

Director/PDMR Shareholding

RNS Number: 6917G Dechra Pharmaceuticals PLC 05 March 2018 5 March 2018 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) Exercise of SAYE options: Dechra Pharmaceuticals PLC announces that on 2 March 20...

All News

23-04-08Dechra – good, but not that goodRichard Beddard

RSS feeds

  • Editorial news feed for LSE:DPH Editorial
  • Regulatory news feed for LSE:DPH Regulatory